Banner - NPPA Connect
Opinion|Videos|January 2, 2025

Understanding Ruxolitinib’s Mechanism of Action in Atopic Dermatitis

The panelist discusses how ruxolitinib treats atopic dermatitis by inhibiting Janus kinase (JAK)1/JAK2 signaling pathways to reduce inflammation and alleviate symptoms of the skin condition.


Latest CME